A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
about
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A multicenter, open-label, lon ...... reatment of episodic migraine.
@en
A multicenter, open-label, lon ...... reatment of episodic migraine.
@nl
type
label
A multicenter, open-label, lon ...... reatment of episodic migraine.
@en
A multicenter, open-label, lon ...... reatment of episodic migraine.
@nl
prefLabel
A multicenter, open-label, lon ...... reatment of episodic migraine.
@en
A multicenter, open-label, lon ...... reatment of episodic migraine.
@nl
P2093
P2860
P1476
A multicenter, open-label, lon ...... reatment of episodic migraine.
@en
P2093
Alan M Rapoport
Egilius L H Spierings
Elimor Brand-Schieber
Kent Allenby
Roger K Cady
Sagar Munjal
P2860
P2888
P356
10.1186/S10194-017-0740-3
P577
2017-03-01T00:00:00Z
P6179
1084249721